Announced Wed, 20 May · 16:06 IST
Investor Conference Call for Q4 & FY26 - Audio Recording
Investor Communications View source PDF
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.9%1-day move
₹2580.90
prior close
₹2613.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.7+0.6+0.4-3.9-4.7-6.4-5.7-6.7-11.1-7.8-1.5-0.2—
Up moveDown movePending
AI summary
Mankind Pharma has published the audio recording of its Q4 and FY26 investor conference call held on May 20, 2026. The recording is accessible on the company's official website. This is a routine regulatory intimation under SEBI LODR regulations, confirming disclosure compliance. The filing itself contains no financial figures, guidance, or strategic commentary — only a reference to the hosted audio/video file.
Likely market impact
Shareholders and analysts can now review the full call at their convenience. No direct stock impact from this filing alone; actual market reaction will depend on content discussed during the call itself.